Life sciences procurement is the sourcing and management of products, services, suppliers, and purchasing processes that support scientific research. In pharma and biotech R&D, it connects researchers’ requirements with supplier selection, purchasing policies, budgets, and delivery planning.
Its effectiveness is visible at the bench: can a research team obtain the right supplies, with the appropriate documentation, in time for a planned experiment? Scientists define what their work requires. Research Operations, procurement, finance, and other supporting teams coordinate the processes that make those supplies accessible.
This guide explains what makes life sciences procurement different, how research organizations structure it, and where practical improvements can reduce administrative work and support experiment continuity.
What is life sciences procurement?
Unlike general business purchasing, life sciences procurement must account for the scientific suitability of reagents, consumables, equipment, and services, as well as product availability and the documentation appropriate to their intended use.
Procurement does not determine which antibody, assay, or instrument will produce valid scientific results. Researchers retain responsibility for those decisions. Procurement helps translate requirements into approved, manageable purchasing arrangements and reliable supply processes.
Purchasing versus procurement in R&D
Purchasing and procurement are related but distinct. Purchasing concerns the execution of individual transactions; procurement establishes the broader supplier arrangements, policies, and information needed to make those transactions work consistently.
Comparison: Purchasing vs. procurement
| Purchasing | Procurement |
|---|---|
| Places and follows up on orders | Establishes supplier and sourcing strategies |
| Addresses immediate supply requirements | Plans for recurring and future research needs |
| Focuses on a specific transaction | Coordinates suppliers, contracts, controls, and data |
| Confirms delivery and receipt | Evaluates price, availability, quality, performance, and risk |
Procurement establishes the purchasing framework. Day-to-day purchasing puts it into practice. Both need to reflect scientific requirements, including which products are acceptable, when they are needed, and who can approve an alternative.
For a step-by-step discussion of requisitions, ordering, receiving, and reconciliation, see our lab supply purchasing guide.
Across all categories, teams may need purchasing records and product documentation such as safety data sheets, certificates of analysis, and lot information. The required documentation and controls depend on the intended scientific use and the organization’s procedures.
What makes life sciences procurement different?
Scientific purchasing carries constraints that a general office-procurement process may not capture. The purchasing model must accommodate uncertainty while preserving enough structure for sound supplier and financial management.
- Changing research priorities. Protocols and experimental plans change, sometimes after supplies have already been requested. Teams need clear ways to modify requirements and manage exceptions.
- Specialized supplier networks. Researchers may require products available only from a niche manufacturer or distributor. Administrative consolidation should not eliminate scientifically necessary options.
- Scientific substitution risk. A less expensive or faster-to-ship product is not necessarily interchangeable. Scientists need to assess suitability before a replacement is approved.
- Delivery and storage considerations. Lead times, cold-chain handling, shipping restrictions, and receiving requirements can affect whether a supply arrives in usable condition.
- Quality and documentation requirements. Exploratory research, regulated studies, and manufacturing may operate under different procedures. Supplier checks, records, and receiving controls should match intended use.
Quality and documentation requirements vary according to the intended use of a product and the organization's procedures. For example, the FDA's current Good Manufacturing Practice (CGMP) regulations govern pharmaceutical manufacturing, but do not apply universally to R&D purchasing.
Life sciences procurement transformation: how approaches evolve
Life sciences procurement transformation often involves changing how scientists, Research Operations, procurement, and finance coordinate purchasing. The following four-stage framework describes common approaches to organizing scientific procurement. It is a planning aid rather than a universal progression: one organization may use different models across locations, research groups, or purchasing categories.
The final stage is described more fully on ZAGENO’s scientific procurement orchestration page. It is not necessary for every organization to adopt that model to improve purchasing performance.
Centralized and lab-managed purchasing
A shared purchasing framework need not centralize scientific product decisions. Researchers can retain selection authority within documented purchasing policies, while procurement coordinates supplier administration, financial controls, and reporting.
| Dimension | Lab-managed purchasing | Shared procurement framework |
|---|---|---|
| Scientific selection | Researchers choose locally | Researchers select suitable products within agreed policies |
| Supplier arrangements | Managed by individual labs or teams | Administrative and commercial relationships can be coordinated |
| Approvals | Processes may differ across teams | Owners and approval rules are defined |
| Visibility | Records may be distributed | Purchasing records can be reviewed across sites and groups |
| Key trade-off | Flexibility, with more duplicate administration | Consistency, with a need for scientific exceptions |
The most useful model gives scientists practical access to specialized supplies while reducing avoidable administrative work. It should make exceptions visible and manageable instead of forcing all research requests into the same procedure.
Benefits and measurable customer outcomes
When procurement aligns with scientific needs, organizations can improve delivery planning, reduce duplicate administration, maintain clearer purchasing records, and gain a stronger view of supplier and project spending. These are potential benefits, not automatic outcomes of centralization.
Customer example: Apogee Therapeutics
ZAGENO’s published Apogee Therapeutics case study reports that, within its first year, the organization centralized purchasing across 98 suppliers, reduced purchase orders processed by 40%, and returned more than 250 hours to scientists. The study also reports more than $260,000 in time savings across procurement and finance.
These customer-reported results illustrate how a coordinated purchasing experience can reduce administrative effort for researchers and financial teams. Actual outcomes depend on purchasing volume, existing processes, configuration, and adoption.
Read the Apogee Therapeutics case study for context and methodology.
Key components of a life sciences procurement strategy
Back to Top
How procurement platforms work with enterprise systems
Enterprise systems provide essential financial and purchasing controls. Specialized procurement platforms may add scientific product discovery, normalized product information, multi-supplier shopping, and order visibility. Responsibilities vary by implementation, so organizations should establish how data and transactions move between the systems before rollout.
One published ZAGENO research institute case study reports a 75% reduction in ordering time following integration with the institute’s purchasing process. Its reported processing cost fell from more than £100 to less than £25 per order. These results describe that customer’s implementation, not a universal integration benchmark.
Review the research institute case study and our lab procurement platform guide for a fuller discussion of software evaluation.
How procurement data supports AI
AI-assisted procurement depends on reliable product, supplier, purchasing, and order-status information. Consistent identifiers and connected records can support product search, spending analysis, recommendations, and the detection of exceptions that require attention.
The appropriate level of automation depends on the available data, system capabilities, and organizational policies. Scientific suitability, supplier approval, and product substitutions still require clearly assigned review responsibilities. Before enabling autonomous actions, teams should define authoritative data sources, permitted actions, and points where human approval is necessary.
For more context, explore ZAGENO’s article on agentic AI in pharmaceutical procurement.
Common implementation problems and how to address them
Successful procurement modernization requires more than adding a purchasing tool. It requires decisions about responsibility, scientific exceptions, system ownership, and how success will be measured.
| Pitfall | What Happens |
|---|---|
| Standard rules do not fit specialized research | Define scientific exception review and assign an owner. |
| A new system adds duplicate data entry | Map system ownership and necessary data transfers before launch. |
| Scientists bypass approved purchasing | Check whether required products are accessible and order status is clear. |
| Supplier consolidation narrows scientific choice | Distinguish administrative consolidation from product and manufacturer restrictions. |
| Backorders lack a clear owner | Assign escalation, researcher communications, and alternative-review responsibilities |
| Success is measured only in purchase price | Include ordering effort, reliability, adoption, and research-related delays. |
Sustainability criteria can be incorporated where relevant to sourcing decisions. Ask suppliers for evidence of environmental practices and weigh those findings alongside scientific suitability, quality, cost, and availability.
Organizations seeking laboratory sustainability resources can consult My Green Lab. Its resources do not establish that every supplier on a given marketplace meets a particular environmental standard.
How ZAGENO supports life sciences procurement
ZAGENO helps pharma and biotech R&D teams coordinate scientific purchasing across suppliers. Researchers can find and order supplies through a shared purchasing experience, while procurement and finance maintain the policies, approvals, and financial processes that govern those purchases.
- Supplier access. A scientific marketplace with 50M+ products from 6,000+ suppliers, including specialized research products.
- Guided buying. Product discovery and purchasing options that can reflect preferred suppliers and established policies.
- Order coordination. Order-status information, exception support, and supplier follow-up through a shared experience.
- Enterprise connectivity. Integration options that connect scientific purchasing with existing procurement and financial systems.
For additional detail on managing supplier relationships, see lab supplier management. Product availability, automation, and integration functionality vary by configuration.
Support research with a more connected purchasing experience
See how ZAGENO helps research teams find supplies, coordinate purchasing, and maintain procurement and financial oversight without requiring scientists to navigate a separate supplier process for every order.
FAQs about life sciences procurement
-
What is life sciences procurement?
Life sciences procurement is the sourcing and management of products, services, suppliers, and purchasing activities that support scientific work. In pharma and biotech R&D, it must account for scientific suitability, timing, documentation, cost, and organizational policies.
-
How is life sciences procurement different from traditional procurement?
It must serve experimental requirements, specialized suppliers, variable lead times, and product-specific quality considerations. A financially preferred option may not be scientifically interchangeable with the requested reagent, consumable, or instrument.
-
Who is responsible for life sciences procurement?
Responsibility is shared. Scientists define scientific requirements and evaluate product suitability. Research Operations coordinates laboratory needs and exceptions. Procurement manages supplier arrangements and purchasing rules; finance handles financial controls and payment. Quality, safety, and IT teams participate where required.
-
Does a life sciences procurement platform replace an ERP?
Not necessarily. Specialized platforms can complement ERP and P2P systems with scientific product discovery and supplier-purchasing capabilities. Each organization should define which systems own approvals, purchase orders, receiving, invoices, and reconciliation.
-
What should an organization measure when improving life sciences procurement?
Useful measures include ordering time, purchase-order volume, supplier onboarding effort, preferred-channel adoption, purchase and delivery exceptions, and spending visibility by team or project. Measurement methods and baselines should be documented before comparing results.
-
How can procurement support experiment continuity?
Teams can connect purchasing priorities with experiment schedules, identify critical supplies early, communicate expected delivery dates, and assign responsibility for backorders and alternatives. Procurement cannot eliminate every disruption, but it can make risks easier to identify and address.
Related resources
